ERBB2 and breast carcinoma: This subset had reduced expression for genes involved in immune response (Fig. 1B) and reduced accessibility at regions proximal to metabolism genes (Fig. S2F), despite no measurable difference in expression for typical breast cancer markers, such as PR, ESR1, and ERBB2 (Fig. S2C).